CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Market Share Analysis
3.6. Brand Share Analysis
3.7. Value Chain Analysis
3.8. Regulatory Guidelines
3.9. Key Regulation Analysis
CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS
5.1. Overview
5.1.1. Market size and forecast
5.2. Obesity
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Diabetes
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Cardiovascular Diseases
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Cancer Research
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Online Platforms
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals and Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Applications
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Applications
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Applications
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Applications
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Applications
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Applications
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Applications
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Applications
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Spain
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Applications
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Italy
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Applications
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Applications
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Applications
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Applications
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Applications
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Applications
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. South Korea
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Applications
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Applications
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Applications
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Applications
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Applications
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. UAE
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Applications
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Applications
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. South Africa
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Applications
7.5.5.4.3. Market size and forecast, by End User
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by Product Type
7.5.5.5.2. Market size and forecast, by Applications
7.5.5.5.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cura Integrative Medicine
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.2. Holistic Health
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.3. Metagenics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.4. GX Sciences Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.5. The Gene Box
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.6. Nutrigenomix Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.7. Xcode Life
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.8. DNA Life
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.9. Interleukin Genetics
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.10. Genova Diagnostics
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
| ※参考情報 ニュートリゲノミクスとは、栄養素と遺伝子の相互作用を研究する分野です。この分野は、個々の遺伝的な背景に基づいて、どの栄養素がどのように健康に影響を与えるかを理解することを目的としています。つまり、遺伝子の違いが栄養素の吸収や代謝に影響を与え、その結果、健康状態にも差が出ることを探求します。ニュートリゲノミクスは、個別化医療やパーソナライズド栄養学の発展に寄与しており、これによりより良い健康管理が可能になります。 ニュートリゲノミクスにはいくつかの種類があります。一つは、遺伝子発現に対する栄養素の影響を調べる「遺伝子-栄養素相互作用」の研究です。これは、特定の栄養素がどの遺伝子の発現を促進したり抑制したりするかを明らかにし、特定の栄養素が体内でどのように機能するのかを理解する手助けとなります。 もう一つの種類は、特定の遺伝子変異がどのように栄養素の必要量に影響を与えるかを研究する「栄養素-遺伝子相互作用」です。たとえば、ある遺伝子変異を持つ人は特定のビタミンをより多く必要とする一方で、別の人はそれを過剰に摂取すると健康に悪影響を及ぼす可能性がある場合です。 ニュートリゲノミクスの用途は多岐にわたります。まず、個別化された食事や栄養指導の提供です。個々の遺伝子情報に基づいた食事計画を作成することで、健康問題の予防や改善を目指します。たとえば、心血管疾患や糖尿病のリスクが高いとされる遺伝子を持つ人に対しては、特定の栄養素や食事スタイルを推奨することができます。 さらに、ニュートリゲノミクスは、スポーツ栄養やサプリメントの分野でも応用が期待されています。アスリートの遺伝子プロファイルに基づいて、最適な栄養戦略を提案することで、パフォーマンスの向上や回復の促進が可能になります。これにより、アスリートは自分の体に最も適した栄養素を効果的に摂取できるようになります。 ニュートリゲノミクスに関連する技術としては、ゲノム解析技術やバイオインフォマティクスの進展が挙げられます。次世代シーケンシング技術や遺伝子解析サービスの発展により、個人の遺伝情報をより簡単に取得できるようになりました。また、バイオインフォマティクスにより、大量の遺伝子情報を解析し、栄養素との相関関係を見出すことが可能となっています。 さらに、マイクロバイオーム研究もニュートリゲノミクスに関係しています。腸内細菌叢（マイクロバイオーム）が栄養素の代謝に及ぼす影響が調査されており、これにつながる研究が進むことで、栄養管理がさらに深化することが期待されています。たとえば、特定の食事が腸内フローラにどのように作用するかを理解することで、より良い食事選択ができるようになります。 最後に、ニュートリゲノミクスの研究はまだ発展途上ですが、今後さまざまな分野での応用が見込まれています。個人の遺伝情報を活用した新しい栄養戦略や治療法の開発は、予防医療や健康管理の新たな形を提供する可能性があります。従って、ニュートリゲノミクスは、現代の健康科学において非常に重要な分野となることでしょう。研究が進むにつれて、より多くの人々がこの分野の恩恵を受けることが期待されています。 |
